Publications for Mitchell S. Cairo

NYMC School of Medicine
NYMC School of Health Sciences and Practice
  • Geyer, M. B., Radhakrishnan, K., Van de Ven, C., Suri, M. S., Ayello, J., & Cairo, M. S. (2014). Enhanced survival during experimental Listeria monocytogenes sepsis in neonatal mice prophylactically treated with Th1 and macrophage immunoregulatory cytokines and mediators  The Pediatric Infectious Disease Journal, 33(12), e330-e337. doi:10.1097/INF.0000000000000442

  • Goldman, S., Smith, L., Galardy, P., Perkins, S. L., Frazer, J. K., Sanger, W., . . . Cairo, M. S. (2014). Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: A Children's Oncology Group report. British Journal of Haematology, 167(3), 394-401.  doi:10.1111/bjh.13040

  • Hitzler, J. K., He, W., Doyle, J., Cairo, M., Camitta, B. M., Chan, K. W., . . . CIBMTR Pediatric Cancer Working Committee. (2014). Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. Pediatric Blood & Cancer, 61(6), 1126-1128. doi:10.1002/pbc.24918

  • Hochberg, J. C., Cairo, M. S., & Friedman, D. M. (2014). Cardio-oncology issues among pediatric cancer and stem cell transplant survivors. Cardiology in Review, 22(6), 268-274.  doi:10.1097/CRD.0000000000000030

  • Hochberg, J. C., El-Mallawany, N. K., & Cairo, M. S. (2014). Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults. Clinical Lymphoma, Myeloma & Leukemia, 14(Suppl.), S6-S13. doi:10.1016/j.clml.2014.04.015

  • Huang, X., Greene, J., Chu, Y., Hamby, C.Cairo, M. S., . . . Zhou, X. (2014). Chimeric antigen receptor (CAR) T cell immunotherapy for poor risk sarcomas. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S184-S185.

  • Lee, S., Yin, C., Ayello, J., Van De Ven, C., & Cairo, M. S. (2014). Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (CAS) system mediated endogenous CD19 gene knockout model in burkitt lymphoma. Cancer Research, 74(19 Suppl.), 3617.

  • Lee, S. , Yin, C., O'Connell, T., Ayello, J., Van De Ven, C., & Cairo, M. S. (2014). Transcription activator-like effector nucleases (TALENs) mediated silencing of Bruton's tyrosine kinase (BTK) inhibits phosphorylation of Erk in Burkitt lymphoma . Cancer Research, 74(19 Suppl.), 3112.  doi:10.1158/1538-7445.AM2014-3112

  • Liao, Y., Itoh, M., Yang, A., Zhu, H., Roberts, S., Highet, A. M., . . . Cairo, M. S. (2014). Human cord blood derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa. Cell Transplantion, 23(3), 303-317. doi:10.3727/096368913X663569

  • Liao, Y., Ivanova, L., Surapaneni, B., Yahr, A., & Cairo, M. S. (2014). Xenotransplantation of human cord blood derived unrestricted somatic stem cells rescue the blistering phenotype in a murine model of recessive dystrophic epidermolysis bullosa. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S185-S186.

  • McClune, B. L., Ahn, K. W., Wang, H. L., Antin, J. H., Artz, A. S., Cahn, J. Y., . . . Cairo, M. S. (2014). Allotransplantation for patients age >/=40 years with non-Hodgkin lymphoma: Encouraging progression-free survival. Biology of Blood and Marrow Transplantation, 20(7), 960-968. doi:10.1016/j.bbmt.2014.03.013

  • McGuinn, C., Geyer, M. B., Jin, Z., Garvin, J. H., Satwani, P., Bradley, M. B., . . . Cairo, M. S. (2014). Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia. Pediatric Blood & Cancer, 61(7), 1289-1294. doi:10.1002/pbc.24976

  • Miles, R., Galardy, P., Giulino, L. G., Goldman, S., & Cairo, M. S. (2014). Childhood and adolescent B-cell lymphoma: Bench to bedside and back to bench. In R. Srivastava, W. Maksymowicz, & W. Lopaczynski (Eds.), Lost in Translation: Barriers to incentives for translational research in medical sciences (pp. 247-285). Singapore: World Scientific Publishing Company.

  • O'Connell, T., Yin, C., Barth, M., Miles, R., Ayello, J., Harrison, L., . . . Cairo, M. (2014). Ibrutinib significantly alters cell proliferation and apoptosis in BL and PMBL: Ibrutinib may be a potential adjuvant therapy in the treatment of BL and/or PMBL. Pediatric Blood and Cancer, 61(Suppl 2), S200-S201.

  • Qualter, E., Satwani, P., Ricci, A., Jin, Z., Geyer, M. B., Alobeid, B., . . . Cairo, M. S. (2014). A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation. Biology of Blood and Marrow Transplantation, 20(8), 1229-1237. doi:10.1016/j.bbmt.2014.04.019

  • Satwani, P., Bavishi, S., Saha, A., Zhao, F., Ayello, J., Chu, Y., . . . Cairo, M. S. (2014). Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity. Cytotherapy, 16(10), 1431–1440. doi:10.1016/j.jcyt.2014.03.008

  • Satwani, P., Jin, Z., Bhatia, M., Garvin, J., George, D., . . . Cairo, M. S. (2014). Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic stem cell transplantation in children, adolescents and young adults with poor risk refractory or recurrent Hodgkin (HL) and non-Hodgkin lymphoma (NHL). Biology of Blood and Marrow Transplantation, 20(2 Suppl.), S85.

  • Smock, K. J., Agarwal, A. M., Lim, M. S., Tripp, S. R., Miles, R. R., Patel, J. L., . . . Cairo, M. S. (2014). Expression of Notch1 and mTOR pathway proteins in pediatric lymphoblastic lymphoma; a Children's Oncology Group report. Journal of Hematopathology, 7(1), 9-14. doi:10.1007/s12308-014-0200-9

  • Talano, J. A., Abikoff, C. M., Dozor, A. J., Friedman, D. M., Shi, Q., . . . Cairo, M. S (2014). Familial haploidentical (FHI) T-cell depleted (TCD) with T-cell addback stem cell transplantation for patients with high-risk sickle cell disease (SCD) (IND 14359) Biology of Blood and Marrow Transplantation, 20(2 Suppl), S135-S136. doi:10.1016/j.bbmt.2013.12.208

  • Talano, J. A., & Cairo, M. S. (2014). Smoothing the crescent curve: Sickle cell disease. Hematology 2014, 2014(1), 468-474. doi:10.1182/asheducation-2014.1.468

  • Talano, J. M., Pulsipher, M. A., Symons, H. J., Militano, O., Shereck, E. B., Giller, R. H., . . . Cairo, M. S. (2014). New frontiers in pediatric Allo-SCT. Bone Marrow Transplantation, 49(9), 1139-1145. doi:10.1038/bmt.2014.89

  • Tiwari, A. A., Ayello, J., Van De Ven, C., Barth, M. J., & Cairo, M. S. (2014). Obinutuzumab (GA101) significantly increases overall survival against CD20+ rituximab-sensitive and-resistant Burkitt (BL) and acute lymphoblastic leukemia (B-ALL): Potential targeted therapy in patients with high risk BL and pre-B-ALL. Cancer Research, 74(19 Suppl.), 2902.

  • Warlick, E. D., Paulson, K., Brazauskas, R., Zhong, X., Miller, A. M., Camitta, B. M., . . . Cairo, M. S. (2014). Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Biology of Blood and Marrow Transplantation, 20(2), 202-208. doi:10.1016/j.bbmt.2013.10.023

  • Wirk, B., Fenske, T. S., Hamadani, M., Zhang, M. J., Hu, Z. H., Akpek, G., . . . Cairo, M. S. (2014). Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Biology of Blood and Marrow Transplantation, 20(7), 951-959. doi:10.1016/j.bbmt.2014.03.014

  • Yin, C., O'Connell, T., Ayello, J., Van De Ven, C., Lee, S., & Cairo, M. S. (2014). Obinutuzumab (GA101) significantly induces antiproliferative effects and programmed cell death, and significantly downregulates cell signaling pathways in primary mediastinal B-cell lymphoma (PMBL): Obinutuzumab may be a future potential targeted agent for treatment of PMBL. Cancer Research, 74(19 Suppl.). 3096.

First Prev 1 2 3 4 5 Next Last